Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Mar, 2020 | Pages:
94 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China. Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market. Further key findings from the report suggest: • Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries • Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period • North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region • The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners • Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Suring number of drugs in preclinical phases
3.4.1.2. Economies of production and scale
3.4.1.3. Increasing R&D expenditure
3.4.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Preclinical CRO: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Preclinical CRO Market : Segment Analysis, by Services, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
4.5.3. Others
Chapter 5. Preclinical CRO Market : Segment Analysis, By End-use, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies
Chapter 6. Preclinical CRO Market : Regional Market Analysis, By Services, 2016 - 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.13.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.10. Indonesia
6.9.11. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.12. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.13. Singapore
6.9.14. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.15. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.16. Philippines
6.9.17. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.18. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.19. Thailand
6.9.20. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.21. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
Chapter 7. Preclinical CRO Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
List of Tables Table 1 List of Secondary Sources Table 2 List of Abbreviations Table 3 Global Preclinical CRO Market, By Region, 2016 - 2027 (USD Million) Table 4 Global Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 5 Global Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 6 North America Preclinical CRO Market, By Country, 2016 - 2027 (USD Million) Table 7 North America Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 8 North America Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 9 U.S. Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 10 U.S. Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 11 Canada Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 12 Canada Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 13 Europe Preclinical CRO Market, By Country, 2016 - 2027 (USD Million) Table 14 Europe Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 15 Europe Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 16 U.K. Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 17 U.K. Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 18 Germany Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 19 Germany Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 20 France Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 21 France Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 22 Italy Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 23 Italy Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 24 Spain Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 25 Spain Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 26 Netherlands Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 27 Netherlands Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 28 Belgium Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 29 Belgium Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 30 Switzerland Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 31 Switzerland Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 32 Russia Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 33 Russia Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 34 Sweden Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 35 Sweden Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 36 Asia Pacific Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 37 Asia Pacific Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 38 China Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 39 China Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 40 Japan Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 41 Japan Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 42 India Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 43 India Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 44 Australia Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 45 Australia Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 46 South Korea Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 47 South Korea Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 48 Malaysia Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 49 Malaysia Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 50 Indonesia Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 51 Indonesia Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 52 Singapore Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 53 Singapore Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 54 Philippines Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 55 Philippines Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 56 Thailand Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 57 Thailand Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 58 Latin America Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 59 Latin America Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 60 Brazil Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 61 Brazil Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 62 Mexico Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 63 Mexico Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 64 Argentina Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 65 Argentina Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 66 Colombia Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 67 Colombia Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 68 Chile Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 69 Chile Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 70 Middle East & Africa Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 71 Middle East & Africa Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 72 South Africa Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 73 South Africa Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 74 Saudi Arabia Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 75 Saudi Arabia Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 76 UAE Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 77 UAE Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 78 Israel Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 79 Israel Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) Table 80 Egypt Preclinical CRO Market, By Services, 2016 - 2027 (USD Million) Table 81 Egypt Preclinical CRO Market, By End-use, 2016 - 2027 (USD Million) List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value-chain-based sizing & forecasting Fig. 6 QFD modeling for market share assessment Fig. 7 Market formulation & validation Fig. 8 Preclinical CRO Market :Market snapshot Fig. 9 Preclinical CRO Market :Market segmentation Fig. 10 Preclinical CRO Market Strategy framework Fig. 11 Parent market outlook Fig. 12 Related/ancillary market outlook Fig. 13 Preclinical CRO Market driver impact Fig. 14 Preclinical CRO Market restraint impact Fig. 15 Preclinical CRO Market porter’s five forces analysis Fig. 16 Preclinical CRO Market PESTEL analysis Fig. 17 Preclinical CRO Market segment dashboard Fig. 18 Preclinical CRO Market : Services movement Analysis Fig. 19 Bioanalysis and DMPK studies market estimates and forecast, 2016 - 2027 (USD Million) Fig. 20 Toxicology testing market estimates and forecast, 2016 - 2027 (USD Million) Fig. 21 Others market estimates and forecast, 2016 - 2027 (USD Million) Fig. 22 Preclinical CRO Market segment dashboard Fig. 23 Preclinical CRO Market : End-use Movement Analysis Fig. 24 Biopharmaceutical companies market estimates and forecast, 2016 - 2027 (USD Million) Fig. 25 Government and academic institutes market estimates and forecast, 2016 - 2027 (USD Million) Fig. 26 Medical device companies market estimates and forecast, 2016 - 2027 (USD Million) Fig. 27 Global Preclinical CRO Market : Regional movement analysis Fig. 28 Global Preclinical CRO Market : Regional outlook and key takeaways Fig. 29 Global market share, by region Fig. 30 North America market estimates and forecast, 2016 - 2027 (USD Million) Fig. 31 U.S. market estimates and forecast, 2016 - 2027 (USD Million) Fig. 32 Canada market estimates and forecast, 2016 - 2027 (USD Million) Fig. 33 Europe market estimates and forecast, 2016 - 2027 (USD Million) Fig. 34 U.K. market estimates and forecast, 2016 - 2027 (USD Million) Fig. 35 Germany market estimates and forecast, 2016 - 2027 (USD Million) Fig. 36 France market estimates and forecast, 2016 - 2027 (USD Million) Fig. 37 Italy market estimates and forecast, 2016 - 2027 (USD Million) Fig. 38 Spain market estimates and forecast, 2016 - 2027 (USD Million) Fig. 39 Netherlands market estimates and forecast, 2016 - 2027 (USD Million) Fig. 40 Belgium market estimates and forecast, 2016 - 2027 (USD Million) Fig. 41 Switzerland market estimates and forecast, 2016 - 2027 (USD Million) Fig. 42 Russia market estimates and forecast, 2016 - 2027 (USD Million) Fig. 43 Sweden market estimates and forecast, 2016 - 2027 (USD Million) Fig. 44 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million) Fig. 45 China market estimates and forecast, 2016 - 2027 (USD Million) Fig. 46 Japan market estimates and forecast, 2016 - 2027 (USD Million) Fig. 47 India market estimates and forecast, 2016 - 2027 (USD Million) Fig. 48 Australia market estimates and forecast, 2016 - 2027 (USD Million) Fig. 49 South Korea market estimates and forecast, 2016 - 2027 (USD Million) Fig. 50 Malaysia market estimates and forecast, 2016 - 2027 (USD Million) Fig. 51 Indonesia market estimates and forecast, 2016 - 2027 (USD Million) Fig. 52 Singapore market estimates and forecast, 2016 - 2027 (USD Million) Fig. 53 Philippines market estimates and forecast, 2016 - 2027 (USD Million) Fig. 54 Thailand market estimates and forecast, 2016 - 2027 (USD Million) Fig. 55 Latin America market estimates and forecast, 2016 - 2027 (USD Million) Fig. 56 Brazil market estimates and forecast, 2016 - 2027 (USD Million) Fig. 57 Mexico market estimates and forecast, 2016 - 2027 (USD Million) Fig. 58 Argentina market estimates and forecast, 2016 - 2027 (USD Million) Fig. 59 Colombia market estimates and forecast, 2016 - 2027 (USD Million) Fig. 60 Chile market estimates and forecast, 2016 - 2027 (USD Million) Fig. 61 Middle East and Africa. market estimates and forecast, 2016 - 2027 (USD Million) Fig. 62 South Africa market estimates and forecast, 2016 - 2027 (USD Million) Fig. 63 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million) Fig. 64 UAE market estimates and forecast, 2016 - 2027 (USD Million) Fig. 65 Israel market estimates and forecast, 2016 - 2027 (USD Million) Fig. 66 Egypt market estimates and forecast, 2016 - 2027 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
